Overcoming endocrine resistance in breast cancer: importance of mTOR inhibition.
about
Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancerTreating Elderly Patients With Hormone Receptor-Positive Advanced Breast CancerSafety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-Palbociclib: an evidence-based review of its potential in the treatment of breast cancerIncidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients: a meta-analysisEstrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer.Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.Everolimus plus exemestane as first-line therapy in HR⁺, HER2⁻ advanced breast cancer in BOLERO-2.Loss of WAVE3 sensitizes triple-negative breast cancers to chemotherapeutics by inhibiting the STAT-HIF-1α-mediated angiogenesis.Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical Trial.
P2860
Q26741153-36EC170C-C59E-4786-B736-E0D34AABA221Q26785496-60EB5386-4422-4CE0-8524-026F2C3A0634Q33433527-81F41FDC-E70C-4358-AE8D-F786C7AA0CA0Q34027724-647BEC01-7599-45FE-B91F-1C4CBCA5B611Q34778631-BD1C5D3A-E4E4-4D83-85D1-EDD19B457E54Q35975638-289870A4-F384-4782-A93F-C83CE4D28314Q37533025-6F61D1B1-0DCC-446A-9F5C-16A5A14822FEQ37534910-19955B99-7EBD-4813-8AD7-E9CA60B2A999Q40492761-5CC2AEEB-F750-4F2E-A2DB-219D1520EF55Q52642671-EC0B9A5E-8651-42D2-B3B9-EDC6C0A30982
P2860
Overcoming endocrine resistance in breast cancer: importance of mTOR inhibition.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Overcoming endocrine resistance in breast cancer: importance of mTOR inhibition.
@en
type
label
Overcoming endocrine resistance in breast cancer: importance of mTOR inhibition.
@en
prefLabel
Overcoming endocrine resistance in breast cancer: importance of mTOR inhibition.
@en
P2860
P356
P1476
Overcoming endocrine resistance in breast cancer: importance of mTOR inhibition.
@en
P2093
Michael Gnant
P2860
P304
P356
10.1586/ERA.12.138
P577
2012-12-01T00:00:00Z